Welcome
Modern organic synthesis allows researchers the power to precisely design, prepare, and vary molecular structures. In our research program, we combine new and established synthetic methods to prepare molecules designed to address two important and interrelated goals. First, we are interested in new molecules that can modulate nucleic acid and protein structure and function. Our second goal is to develop new materials with unique optical and electronic properties. A material’s properties are defined not only by the arrangement of atoms at the molecular level but by the interaction between these molecules in solution (association) or in the solid state (packing). Both of our research goals are intimately linked through organic chemistry and molecular recognition. We are poised to make fundamental discoveries that could impact some of societies most challenging problems in fields ranging from medicine to energy.
(Please See Research Page for More Info)
News
February 2017
- Blast off! Congratulations to the entire team at Arrakis Therapeutics for completing a $38 million Series A financing round. The Series A was led by Canaan Partners with participation by Advent Life Sciences, Pfizer Inc., Celgene Corporation, Osage University Partners, and biotech industry leader Henri Termeer. The RNA-targeting exploration begins!
For more information on Arrakis see: arrakistx.com
For more news on Arrakis see: C&EN News Article, Yahoo Finance Article, Businesswire Article, and Endpoints News Article.
December 2016
- Big welcome to our new first year PhD students, Alex Kasznel and Sam Melton!
November 2016
- Congratulations to the lab on a spectacular series of 2016 manuscripts that were published in JACS, Angewandte, Organic Letters, Chem. Comm, and Nature Nanotechnology.
August 2016
- Congratulations to the lab for all their hard work and contributions to our most recent NIH R01 funding. Great work!
May 2016
- Congratulations to Steph, Mai, and Yitao, the first class of PhD students to graduate from the Chenoweth lab. Their incredibly productive thesis work laid the foundation for three new areas in our lab. We wish Steph all the best in her new postdoc with Bobby Arora at NYU, we wish Mai all the best in her new postdoc with Kai Johnsson at Max Planck, and we wish Yitao all the best in his new postdoc with Bruce Lipshutz at UCSB.